Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
CRO
Charles River's revenue drops amid industry restructuring work
Revenue for the quarter was $1.01 billion, down from $1.03 billion in both last quarter and the third quarter of 2023.
Darren Incorvaia
Nov 6, 2024 3:29pm
Dexcom posts mixed-bag earnings report amid Stelo rollout
Oct 25, 2024 1:30pm
Irish CRO giant Icon plots layoffs after underwhelming Q3
Oct 25, 2024 1:19pm
Boston Scientific posts 177% EP growth, pauses Farapulse study
Oct 23, 2024 11:58am
Intuitive Surgical stock surges 10% amid da Vinci 5 demand
Oct 18, 2024 3:30pm
Flying solo, Grail to cut 30% of staff, narrow cancer test focus
Aug 14, 2024 11:30am
